The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 ...

Engaging in more than 150 minutes of physical activity per week quadrupled the odds of reversing prediabetes to normal ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with significant health benefits.

(HealthDay News) — The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 weeks in adults with early type 2 diabetes ...

Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...

Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving ...

For adult women with overweight or obesity and T2D, replacing diet beverages with water is associated with greater weight loss and T2D remission.

Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...

Orfoglipron was associated with improved glycemic control and weight reduction among patients with early-stage type 2 diabetes.

A 5-day fasting-mimicking diet can help improve blood sugar control in type 2 diabetes, according to a recent clinical trial.

Combination therapy with a long-acting amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist results in ...